The present disclosure is directed to a drug delivery system in which urate oxidase and
metal-based nanoparticles for hydrogen peroxide degradation are loaded in a temperature …

It is an object of the present invention to provide a composition for uric acid decomposition
by removing hydrogen peroxide generated by uric acid decomposition, by using gold …

An orally administrable pharmaceutical preparation contain ing a protein. More particularly,
an orally administrable pharmaceutical preparation including a protein loaded on metal …

Disclosed herein is a nanoparticle comprising a copolymer comprising a polyethylene glycol
polymer, a polyhydroxylated polymer, and a peroxide-sensitive pendant group; a glucose …

Disclosed herein is a nanoparticle comprising a copolymer comprising a polyethylene glycol
polymer, a polyhydroxylated polymer, and a peroxide-sensitive pendant group; a glucose …

US20090269425A1 - Formulation and method for relieving or preventing symptoms
associated with uric acid crystals - Google Patents US20090269425A1 - Formulation and …

METHOD FOR PRODUCING NANOPARTICLES translational diffusion coefficient (D). The
size of a particle is calculated from the translational diffusion coefficient by using the Stokes …

Provided herein are methods and compositions and kits related to uricase compositions
and/or compositions comprising synthetic nanocarriers comprising an immunosuppressant …

US20160303163A1 - Pharmaceutical composition for preventing or treating iron deficiency,
comprising iron oxide nanoparticles - Google Patents US20160303163A1 - Pharmaceutical …

US9149500B2 - Method and process for relieving or preventing symptoms - Google Patents
US9149500B2 - Method and process for relieving or preventing symptoms - Google Patents …